A Solution Weight Lifters Can Sink Their (Aching) Teeth Into

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The new chemical entity from Xgene Pharmaceuticals, XG005, targets both anti-nociceptive and anti-neuropathic pain pathways.

Keith A. Reynolds

October 1st 2024

5 Elemental Facts About Electronic Cigarettes All Clinicians Should Know

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Cameron Santoro

December 30th 2024

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The 5 summaries that follow cover harmful ingredients, associated health risks, industry marketing tactics, and current regulatory efforts.

October 25th 2023

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

New Treatment Approved for Congenital Adrenal Hyperplasia: Daily Dose

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.

Novel Nonopioid Dual Action Analgesic Highly Effective Against Post-Surgical Pain in Phase 2b Trial

Your daily dose of the clinical news you may have missed.

Related Content

Grace Halsey

January 2nd 2025

Primary Viewpoints: Immunizations with Dr Steven P. Furr

The new chemical entity from Xgene Pharmaceuticals, XG005, targets both anti-nociceptive and anti-neuropathic pain pathways.

Keith A. Reynolds

October 1st 2024

5 Elemental Facts About Electronic Cigarettes All Clinicians Should Know

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Cameron Santoro

December 30th 2024

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

The 5 summaries that follow cover harmful ingredients, associated health risks, industry marketing tactics, and current regulatory efforts.

October 25th 2023

FDA Approves First Generic of Liraglutide Injection to Improve Glycemic Control in Patients with Type 2 Diabetes

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

New Treatment Approved for Congenital Adrenal Hyperplasia: Daily Dose

The FDA has approved the first generic once-daily GLP-1 injection for the improvement of glycemic control for type 2 diabetes in patients 10 years and up.